tales from the trenches
From academia to entrepreneurship: A conversation with Exicure CEO David Giljohann
Earlier this month, David Giljohann, CEO of immunotherapy company Exicure, shared his entrepreneurial story at Tales from the Trenches. David’s journey has taken him from graduate training in a university lab to the helm of Exicure, a Chicago-based biotechnology company that is pioneering the field of immunotherapy. In just seven years, David has taken Exicure public, raised more than $100 mill…